Independent Innovator and Repurposing Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Independent Innovator and Repurposing Act - Establishes procedures under which the term of an unexpired patent claiming a method of using a biological product shall be extended for five years from its original expiration date.
Requires an application for such an extension to demonstrate that: (1) the patent was issued to an independent innovator, and (2) the owner of record is the independent innovator or a small business (with fewer than 500 employees and which is not affiliated with the holder of the marketing application approved under licensing requirements of the Public Health Service Act for the commercial marketing of such biological product) in which the independent innovator has an ownership interest.
Defines "independent innovator" as a person or entity that obtains a method of use patent for a biological product and is not, at the time of invention or patent filing, affiliated with the holder of an approved application for the commercial marketing of the product.
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4287: Independent Innovator and Repurposing Act. 113th Congress. Open America. https://openamerica.io/bill/113-HR-4287/
"H.R. 4287: Independent Innovator and Repurposing Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-4287/.
H.R. 4287, 113th Cong. (2026), https://openamerica.io/bill/113-HR-4287/.
[H.R. 4287: Independent Innovator and Repurposing Act](https://openamerica.io/bill/113-HR-4287/)